關鍵字
 
Q W E R T Y U I O P
A S D F G H J K L
Z X C V B N M
首頁
  略過巡覽連結登入系統 / 首頁 / 消息內容 檢驗醫學科網站 檢驗通告 檢體採集原則


9.
異動Anti-nuclear antibody(ANA)(FSIANA)檢驗報告格式及方式
 2021.05.12

檢驗醫學部通知

   檢字110024

  期:20210512

受文者:彰基體系全體同工

  旨:異動Anti-nuclear antibody(ANA)(FSIANA)檢驗報告格式及方式

  明:

1.      20210514日起異動Anti-nuclear antibody(ANA)(FSIANA)檢驗報告欄位及報告方式

子欄位

報告子欄位名稱:型態(AC分類)

報告方式

 1

ANA reactivity

1:80(-)1:80(+)

1:160(+)

 2

Nuclear Homogeneous (AC1)

ANA reactivity報告為1:160(+)時,會於效價1:160(+)之型態核發對應效價(1:1601:3201:6401:12801:25601:51201:5120)

3

Nuclear dense fine speckled (AC2)

4

Centromere (AC3)

5

Nuclear fine speckled (AC4)

6

Nuclear large/coarse speckled (AC5)

7

Multiple nuclear dots (AC6)

8

Few nuclear dots (AC7)

9

Homogeneous nucleolar (AC8)

10

Clumpy nucleolar (AC9)

11

Punctate nucleolar (AC10)

12

Smooth nuclear envelope (AC11)

13

Punctate nuclear envelope (AC12)

14

PCNA-like (AC13)

15

CENP-F-like (AC14)

16

Cytoplasmic fibrilliar linear (AC15)

17

Cytoplasmic fibrilliar filamentous (AC16)

18

Cytoplasmic fibrillar segmental (AC17)

19

Cytoplasmic discrete dots/GW-body like (AC18)

20

Cytoplasmic dense fine speckled (AC19)

21

Cytoplasmic fine speckled (AC20)

22

Cytoplasmic reticular/AMA (AC21)

23

Polar/Golgi-like (AC22)

24

Rods and rings (AC23)

25

Centrosome (AC24)

26

Spindle fiber (AC25)

27

NuMA-like (AC26)

28

Intercellular bridge (AC27)

29

Mitotic chromosomal envelope (AC28)

30

Topo I-like (AC29)

31

uncharacteristics pattern in nuclear

32

uncharacteristics pattern in cytoplasm

33

uncharacteristics pattern in mitotic

 

2.      報告方式說明:

(A)   本部ANA檢驗測試,採1:80稀釋上機並分析螢光染色效價(titer)

(B)   ANA之染色螢光強度呈現無螢光或弱螢光,於子欄位一核發「1:80(-)?;

(C)   染色螢光強度呈現1:80(+)時,不作ANA型態鑑別,僅核發1:80(+)

(D)  染色螢光強度呈現≥1:160(+)時,執行ANA型態鑑別並核發對應效價。

(E)   無論效價為何,ANA之型態表現均以超聯結方式呈現於LB04之附件。

3.      相關問題,請聯絡檢驗醫學部總醫檢師蕭玉鑫,分機5940

 

 

檢驗醫學部主任 林正修



 
  財團法人彰化基督教醫院 無標題文件
網站瀏覽人數:3496125   線上人數:23